Cargando…
Coronavirus disease 2019 and cardiovascular disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease 2019 (COVID-19) pandemic, is a type of RNA virus that is nonsegmented. Cardiovascular diseases (CVDs) increase the mortality risk of patients. In this review article, we overview the existing evide...
Autores principales: | Song, Jenn-Yeu, Huang, Jian-You, Hsu, Yi-Chiung, Lo, Men-Tzung, Lin, Chen, Shen, Ta-Chung, Liao, Min-Tser, Lu, Kuo-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399840/ https://www.ncbi.nlm.nih.gov/pubmed/37545802 http://dx.doi.org/10.4103/tcmj.tcmj_219_22 |
Ejemplares similares
-
Cardiovascular disease management during the coronavirus disease 2019 pandemic
por: Lee, Wen-Hsien, et al.
Publicado: (2020) -
Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease
por: Song, Jenn-Yeu, et al.
Publicado: (2020) -
Potential adverse effects of coronavirus disease 2019 on the cardiovascular system
por: Bing-Yin, Wang, et al.
Publicado: (2021) -
Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications
por: Ma, Lulu, et al.
Publicado: (2021) -
Left Ventricular Hypertrophy Geometry and Vascular Calcification Co-Modify the Risk of Cardiovascular Mortality in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study
por: Chao, Chia-Ter, et al.
Publicado: (2023)